Latest Property Portfolio News

HomeCo Daily Needs REIT has reported a robust half-year result, doubling its profit to $243.5 million driven by significant fair value gains on its property portfolio, while maintaining stable distributions to unitholders.

US Masters Residential Property Group aims to divest its entire portfolio by the end of 2026, signalling an end to its operations. The group will prepare 2025 financials on a non-going concern basis, reflecting this strategic wind-down.

Dexus Convenience Retail REIT has reported a striking 143.8% increase in net profit for the half-year to December 2025, underpinned by strong portfolio occupancy and rising property valuations. The REIT reaffirmed its FY26 guidance, signalling confidence in its defensive income strategy and development pipeline.

Acusensus Limited has settled its patent litigation with Redflex Traffic Systems, issuing over six million shares and paying US$6 million in cash to resolve the dispute. The agreement clears the way for Acusensus to continue its road safety technology operations unimpeded.

Garda Property Group has upgraded its FY26 earnings guidance by 10%, reduced gearing to 20.8%, and outlined ambitious plans to expand its Brisbane industrial portfolio and lending operations.

Centuria Office REIT has reported a strong half-year performance with a 56% increase in revenue and a significant turnaround to a $61.5 million net profit, while maintaining steady distributions.

Adisyn Ltd has appointed Arye Kohavi, CEO of 2D Generation, as its new Managing Director to spearhead its semiconductor technology strategy following a strategic review and recent acquisition.

Talga Group has reported a quarter of significant commercial and regulatory progress, including its largest anode shipment, expanded product offerings, and major mining approvals in Sweden, supported by substantial capital raises and new patents.

Recce Pharmaceuticals progresses its Phase 3 diabetic foot infection trial in Indonesia, reports promising preclinical data for inhaled RECCE 327, and secures significant R&D funding and patent protection.

BluGlass Limited has extended its contract with the U.S. Department of War by A$1.05 million and appointed a refreshed Board to accelerate its commercial growth in visible laser technology. The company is advancing its GaN laser portfolio amid a US$100 million project pipeline and ongoing R&D investments.

Nanollose has advanced its largest pilot production of Nullarbor™ fibre, integrating a refined microbial cellulose process that promises easier adoption by textile manufacturers. The company also bolstered its intellectual property portfolio and secured additional funding post-quarter.

Argent BioPharma has restructured its acquisition of AusCann assets to sharpen its clinical focus and secured a substantial A$11 million financing facility, positioning itself for growth in 2026.